Emami Resultados de beneficios anteriores

Pasado controles de criterios 3/6

Emami ha aumentado sus beneficios a una tasa media anual de 22.4%, mientras que los beneficios de la industria de Personal Products han experimentado un crecimiento de 5.6% anual. Los ingresos han ido creciendo a una tasa media de 6.8% al año. La rentabilidad financiera de Emami es de 29.8%, y sus márgenes netos son de 20.4%.

Información clave

22.4%

Tasa de crecimiento de los beneficios

23.1%

Tasa de crecimiento del BPA

Crecimiento de la industria Personal Products	7.9%
Tasa de crecimiento de los ingresos	6.8%
Rentabilidad financiera	29.8%
Margen neto	20.4%
Próxima actualización de resultados	29 May 2024

Actualizaciones de resultados anteriores recientes

Recent updates

These 4 Measures Indicate That Emami (NSE:EMAMILTD) Is Using Debt Reasonably Well

Feb 27

Emami (NSE:EMAMILTD) Is Due To Pay A Dividend Of ₹4.00

Feb 09

Here's Why We Think Emami (NSE:EMAMILTD) Might Deserve Your Attention Today

Feb 04

Emami's (NSE:EMAMILTD) Dividend Will Be ₹4.00

Nov 18

Emami (NSE:EMAMILTD) Seems To Use Debt Quite Sensibly

Nov 13

With EPS Growth And More, Emami (NSE:EMAMILTD) Makes An Interesting Case

Oct 24

Is Now An Opportune Moment To Examine Emami Limited (NSE:EMAMILTD)?

Sep 27

We Ran A Stock Scan For Earnings Growth And Emami (NSE:EMAMILTD) Passed With Ease

Jul 26

Emami (NSE:EMAMILTD) Could Easily Take On More Debt

Jul 08

Is Now The Time To Put Emami (NSE:EMAMILTD) On Your Watchlist?

Apr 14

Is Emami (NSE:EMAMILTD) Using Too Much Debt?

Mar 24

Emami (NSE:EMAMILTD) Has Affirmed Its Dividend Of ₹4.00

Feb 06

Should You Investigate Emami Limited (NSE:EMAMILTD) At ₹486?

Jan 19

Is Emami (NSE:EMAMILTD) A Risky Investment?

Dec 13

If You Like EPS Growth Then Check Out Emami (NSE:EMAMILTD) Before It's Too Late

Nov 25

Is There Now An Opportunity In Emami Limited (NSE:EMAMILTD)?

Oct 21

Is Emami (NSE:EMAMILTD) Using Too Much Debt?

Sep 08

Here's Why I Think Emami (NSE:EMAMILTD) Is An Interesting Stock

Aug 20

Why Emami Limited (NSE:EMAMILTD) Could Be Worth Watching

Jul 16

Is Emami (NSE:EMAMILTD) A Risky Investment?

Jun 09

Here's Why I Think Emami (NSE:EMAMILTD) Might Deserve Your Attention Today

May 21

Is It Time To Consider Buying Emami Limited (NSE:EMAMILTD)?

Apr 04

Is Emami Limited's (NSE:EMAMILTD) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Mar 17

Tread With Caution Around Emami Limited's (NSE:EMAMILTD) 1.8% Dividend Yield

Feb 27

Here's Why We Think Emami (NSE:EMAMILTD) Is Well Worth Watching

Feb 12

Don't Race Out To Buy Emami Limited (NSE:EMAMILTD) Just Because It's Going Ex-Dividend

Jan 30

Emami Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Jan 29

What Is The Ownership Structure Like For Emami Limited (NSE:EMAMILTD)?

Jan 22

Investors Who Bought Emami (NSE:EMAMILTD) Shares A Year Ago Are Now Up 51%

Jan 09

What Does Emami's (NSE:EMAMILTD) CEO Pay Reveal?

Dec 25

Here's Why We Think Emami's (NSE:EMAMILTD) Statutory Earnings Might Be Conservative

Dec 10

At ₹416, Is Emami Limited (NSE:EMAMILTD) Worth Looking At Closely?

Nov 25

It Might Not Be A Great Idea To Buy Emami Limited (NSE:EMAMILTD) For Its Next Dividend

Nov 07

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero Emami. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

NSEI:EMAMILTD Ingresos, gastos y beneficios (INR Millions)
Fecha	Ingresos	Beneficios	Gastos G+A
31 Dec 23	35,228	7,191	10,103
30 Sep 23	35,092	6,978	9,892
30 Jun 23	34,581	7,035	9,681
31 Mar 23	34,057	6,396	9,399
31 Dec 22	33,428	8,511	9,419
30 Sep 22	33,311	8,339	9,258
30 Jun 22	33,094	8,350	8,714
31 Mar 22	31,872	8,390	8,475
31 Dec 21	31,524	5,707	8,280
30 Sep 21	31,142	5,597	8,294
30 Jun 21	30,601	4,929	8,238
31 Mar 21	28,805	4,547	7,720
31 Dec 20	26,825	3,903	7,346
30 Sep 20	25,615	3,257	7,157
30 Jun 20	24,876	3,033	7,022
31 Mar 20	26,549	3,029	7,779
31 Dec 19	27,609	3,357	7,767
30 Sep 19	27,593	3,292	7,625
30 Jun 19	27,272	3,158	7,532
31 Mar 19	26,946	3,032	7,598
31 Dec 18	26,703	3,073	7,496
30 Sep 18	26,162	3,168	7,480
30 Jun 18	26,161	3,328	7,420
31 Mar 18	25,305	3,071	7,343
31 Dec 17	24,875	3,302	7,039
30 Sep 17	24,446	3,174	6,845
30 Jun 17	23,887	2,848	6,881
31 Mar 17	24,882	3,404	6,847
31 Dec 16	27,855	3,347	8,029
30 Sep 16	27,849	3,347	8,003
30 Jun 16	27,310	3,291	7,850
31 Mar 16	23,583	3,635	6,454
31 Dec 15	25,067	4,215	8,092
30 Sep 15	24,104	4,711	7,671
30 Jun 15	23,254	5,025	7,373
31 Mar 15	22,172	4,856	5,659
31 Dec 14	21,093	4,584	6,296
30 Sep 14	20,017	4,254	5,895
30 Jun 14	19,189	4,126	5,595
31 Mar 14	18,208	4,025	5,211
31 Dec 13	18,316	3,853	5,054
30 Sep 13	17,954	3,496	5,154
30 Jun 13	17,493	3,288	5,048

Ingresos de calidad: EMAMILTD tiene ganancias de alta calidad.

Margen de beneficios creciente: Los actuales márgenes de beneficio(20.4%) de EMAMILTD son inferiores a los del año pasado (25.5%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: En los últimos 5 años, los beneficios de lEMAMILTD han crecido significativamente en un 22.4% al año.

Acelerando crecimiento: EMAMILTD ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.

Beneficios vs. Industria: EMAMILTD tuvo un crecimiento negativo de los beneficios (-15.5%) durante el año pasado, lo que dificulta la comparación con la media de la industria Personal Products (10.6%).

Emami Resultados de beneficios anteriores

Pasado controles de criterios 3/6

Información clave

Actualizaciones de resultados anteriores recientes

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Full year 2023 earnings: EPS misses analyst expectations

Emami Limited to Report Q4, 2024 Results on May 30, 2024

Emami Limited to Report Q1, 2024 Results on Aug 07, 2023

Full year 2023 earnings: EPS misses analyst expectations

Recent updates

Emami Limited (BSE:531162) signed a share purchase agreement to acquire 4.64% stake in Brillare Science Pvt. Ltd. from founder and other shareholders of Brillare Science Pvt. Ltd.

Is There Now An Opportunity In Emami Limited (NSE:EMAMILTD)?

Dividend of ₹4.00 announced

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Emami Limited Approves Second Interim Dividend for the Financial Year 2023-24

Investor sentiment improves as stock rises 16%

Emami (NSE:EMAMILTD) Seems To Use Debt Rather Sparingly

Emami (NSE:EMAMILTD) Has Affirmed Its Dividend Of ₹4.00

Emami Limited Declares Interim Dividend for the Financial Year 2023-24

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Emami Limited (BSE:531162) completed the acquisition of 26% stake in Axiom Ayurveda Private Limited

Emami Limited (BSE:531162) entered into definitive agreement to acquire 26% stake in Axiom Ayurveda Private Limited.

Emami Limited Announces Change in Management

Manipal Health Enterprises Pvt Ltd acquired 84% stake in AMRI Hospitals Ltd. from Emami Limited (BSE:531162).

Manipal Health Enterprises Pvt Ltd acquired 84% stake in AMRI Hospitals Ltd. from Emami Limited (BSE:531162).

Emami Limited Announces Changes to the Senior Management Personnel

Insider recently bought ₹1.0m worth of stock

Emami May Seal AMRI Sale to Manipal Group This Month

Price target increased by 7.6% to ₹517

Emami Limited Announces Cessation of Mr. Vinod Rao, President-CCD, Personnel of Senior Management Effective from the Closing Hours of July 31, 2023

Is Now The Time To Look At Buying Emami Limited (NSE:EMAMILTD)?

Full year 2023 earnings: EPS misses analyst expectations

Emami Limited to Report Q4, 2024 Results on May 30, 2024

Emami Limited Proposes Two Interim Dividends for the Financial Year 2022-23

Emami Limited, Annual General Meeting, Aug 23, 2023

Does Emami (NSE:EMAMILTD) Have A Healthy Balance Sheet?

Emami Limited to Report Q1, 2024 Results on Aug 07, 2023

Emami Limited Approves Executive Changes

Full year 2023 earnings: EPS misses analyst expectations

What Is Emami Limited's (NSE:EMAMILTD) Share Price Doing?

These 4 Measures Indicate That Emami (NSE:EMAMILTD) Is Using Debt Reasonably Well

Emami (NSE:EMAMILTD) Is Due To Pay A Dividend Of ₹4.00

Price target decreased by 7.3% to ₹510

Third quarter 2023 earnings: EPS exceeds analyst expectations

Emami Limited Declares Second Interim Dividend for the Financial Year 2022-23

Here's Why We Think Emami (NSE:EMAMILTD) Might Deserve Your Attention Today

Emami Limited to Report Q3, 2023 Results on Feb 03, 2023

Max Healthcare Reportedly Eyeing AMRI Hospitals

Emami's (NSE:EMAMILTD) Dividend Will Be ₹4.00

Second quarter 2023 earnings: EPS exceeds analyst expectations

Emami (NSE:EMAMILTD) Seems To Use Debt Quite Sensibly

Second quarter 2023 earnings: EPS exceeds analyst expectations

Emami Limited Declares Interim Dividend for the Financial Year 2022-23

With EPS Growth And More, Emami (NSE:EMAMILTD) Makes An Interesting Case

Emami Limited to Report Q2, 2023 Results on Nov 11, 2022

Is Now An Opportune Moment To Examine Emami Limited (NSE:EMAMILTD)?

Emami Limited, Annual General Meeting, Sep 09, 2022

First quarter 2023 earnings released: EPS: ₹1.67 (vs ₹1.75 in 1Q 2022)

We Ran A Stock Scan For Earnings Growth And Emami (NSE:EMAMILTD) Passed With Ease

Emami Limited (BSE:531162) acquired 30% stake in Cannis Lupus Services India Private Limited.

Emami Limited to Report Q1, 2023 Results on Jul 29, 2022

Emami (NSE:EMAMILTD) Could Easily Take On More Debt

Full year 2022 earnings: EPS exceeds analyst expectations

Is Now The Time To Put Emami (NSE:EMAMILTD) On Your Watchlist?

Emami Limited Announces Executive Changes

Is Emami (NSE:EMAMILTD) Using Too Much Debt?

Emami Limited (BSE:531162) acquired 19% equity stake in Tru Native F&B Private Limited.

Emami (NSE:EMAMILTD) Has Affirmed Its Dividend Of ₹4.00

Emami Limited (BSE:531162) announces an Equity Buyback for INR 1,620 million worth of its shares.

Emami Ltd Restructures Its Board, Effective April 1, 2022

Third quarter 2022 earnings: EPS exceeds analyst expectations

Emami Limited Announces Declaration of Second Interim Dividend

Should You Investigate Emami Limited (NSE:EMAMILTD) At ₹486?

Is Emami (NSE:EMAMILTD) A Risky Investment?

If You Like EPS Growth Then Check Out Emami (NSE:EMAMILTD) Before It's Too Late

Second quarter 2022 earnings released: EPS ₹4.17 (vs ₹2.66 in 2Q 2021)

Upcoming dividend of ₹4.00 per share

Is There Now An Opportunity In Emami Limited (NSE:EMAMILTD)?

Is Emami (NSE:EMAMILTD) Using Too Much Debt?

Emami Limited to Hit the Indian Market with Its Newest Offering Emasol-A Complete Range for Home Hygiene Products

Desglose de ingresos y gastos
Beta